MORGAN STANLEY - CALUMET SPECIALTY PRODS PTNR ownership

CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 58 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CALUMET SPECIALTY PRODS PTNR
ValueSharesWeighting
Q3 2023$4,107,761
-35.8%
215,066
-46.7%
0.00%
-100.0%
Q2 2023$6,402,714
-31.8%
403,702
-25.3%
0.00%0.0%
Q1 2023$9,392,604
-37.3%
540,426
-39.1%
0.00%
-50.0%
Q4 2022$14,982,705
+116.6%
887,601
+64.4%
0.00%
+100.0%
Q3 2022$6,917,000
+190.8%
539,962
+135.8%
0.00%
Q2 2022$2,379,000
+36.2%
229,015
+78.4%
0.00%
Q1 2022$1,747,000
-65.0%
128,348
-66.0%
0.00%
-100.0%
Q4 2021$4,988,000
+739.7%
377,865
+403.1%
0.00%
Q3 2021$594,000
-48.0%
75,114
-54.8%
0.00%
Q2 2021$1,143,000
-22.0%
166,302
-30.8%
0.00%
Q1 2021$1,466,000
+109.4%
240,347
+7.4%
0.00%
Q4 2020$700,000
+212.5%
223,761
+154.7%
0.00%
Q3 2020$224,000
-44.3%
87,852
-50.2%
0.00%
Q2 2020$402,000
-32.4%
176,329
-68.9%
0.00%
Q1 2020$595,000
-80.4%
566,436
-32.1%
0.00%
-100.0%
Q4 2019$3,043,000
+66.0%
833,719
+65.5%
0.00%
Q3 2019$1,833,000
-13.4%
503,890
-0.2%
0.00%
-100.0%
Q2 2019$2,116,000
+94.1%
505,040
+64.9%
0.00%
Q1 2019$1,090,000
+109.6%
306,205
+30.2%
0.00%
Q4 2018$520,000
-91.8%
235,162
-76.3%
0.00%
-100.0%
Q3 2018$6,360,000
-29.9%
993,713
-18.4%
0.00%0.0%
Q2 2018$9,075,000
-2.9%
1,218,120
-8.2%
0.00%
-33.3%
Q1 2018$9,350,000
-21.1%
1,326,257
-13.9%
0.00%0.0%
Q4 2017$11,856,000
-25.9%
1,539,802
-19.7%
0.00%
-40.0%
Q3 2017$16,010,000
+345.1%
1,917,337
+126.4%
0.01%
+400.0%
Q2 2017$3,597,000
-32.8%
846,795
-39.9%
0.00%0.0%
Q1 2017$5,354,000
+7.9%
1,408,876
+13.5%
0.00%0.0%
Q4 2016$4,964,000
+229.0%
1,240,886
+270.8%
0.00%0.0%
Q3 2016$1,509,000
-7.8%
334,683
+0.2%
0.00%0.0%
Q2 2016$1,636,000
-70.7%
333,973
-29.8%
0.00%
-50.0%
Q1 2016$5,589,000
-67.4%
475,628
-44.7%
0.00%
-66.7%
Q4 2015$17,133,000
+24.5%
860,510
+51.9%
0.01%
+20.0%
Q3 2015$13,759,000
-12.0%
566,671
-7.7%
0.01%0.0%
Q2 2015$15,637,000
+10.4%
614,191
+4.3%
0.01%0.0%
Q1 2015$14,168,000
+68.5%
589,120
+57.0%
0.01%
+66.7%
Q4 2014$8,409,000
-17.3%
375,236
+1.3%
0.00%
-25.0%
Q3 2014$10,169,000
-17.3%
370,464
-4.2%
0.00%
-20.0%
Q2 2014$12,301,000
-56.5%
386,837
-64.7%
0.01%
-58.3%
Q1 2014$28,309,000
-61.3%
1,095,548
-61.0%
0.01%
-61.3%
Q4 2013$73,071,000
-4.5%
2,808,299
+0.1%
0.03%
-13.9%
Q3 2013$76,550,000
-28.8%
2,805,063
-5.1%
0.04%
-33.3%
Q2 2013$107,485,0002,954,5540.05%
Other shareholders
CALUMET SPECIALTY PRODS PTNR shareholders Q4 2020
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 2,249,209$7,040,0007.61%
Adams Asset Advisors, LLC 4,555,224$14,257,0003.90%
KNOTT DAVID M 2,645,000$8,279,0003.75%
Springhouse Capital Management, LP 356,722$1,117,0001.08%
Barnett & Company, Inc. 309,882$969,0000.61%
Windsor Wealth Management, Inc. 206,176$645,0000.16%
Danda Trouve Investment Management, Inc. 17,738$56,0000.07%
O'Brien Greene & Co. Inc 33,001$103,0000.04%
Plancorp, LLC 45,000$141,0000.04%
Accel Wealth Management 10,306$32,0000.03%
View complete list of CALUMET SPECIALTY PRODS PTNR shareholders